您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:天美生物2022年度报告 - 发现报告
当前位置:首页/财报/招股书/报告详情/

天美生物2022年度报告

2023-02-10美股财报陈***
天美生物2022年度报告

UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION WASHINGTON,D.C.20549 FORM20-F (MarkOne) ☐REGISTRATIONSTATEMENTPURSUANTTOSECTION12(b)OR12(g)OFTHESECURITIESEXCHANGEACTOF1934 OR ☒ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedSeptember30,2022OR ☐TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Forthetransitionperiodfromto OR ☐SHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Dateofeventrequiringthisshellcompanyreport:Commissionfilenumber:001-40517 BONNATURALLIFELIMITED (ExactNameofRegistrantasSpecifiedinItsCharter) NotApplicable (TranslationofRegistrant’sNameIntoEnglish) CaymanIslands (JurisdictionofIncorporationorOrganization) C601,GazelleValley,No.69JinyeRoad. Xi’anHi-techZone,Xi’an,ChinaPeople’sRepublicofChina (AddressofPrincipalExecutiveOffices) YongweiHu,ChairmanandChiefExecutiveOfficer C601,GazelleValley,No.69JinyeRoad. Xi’anHi-techZone,Xi’an,ChinaPeople’sRepublicofChinaTel:+0086-29-88346301 bonnatural@appchem.cn (Name,Telephone,E-mailand/orFacsimilenumberandAddressofCompanyContactPerson)SecuritiesregisteredortoberegisteredpursuanttoSection12(b)oftheAct: TitleofEachClassTradingSymbol(s) NameofEachExchangeOnWhichRegistered CommonStock,$0.0001parvalueBONNASDAQCapitalMarket SecuritiesregisteredortoberegisteredpursuanttoSection12(g)oftheAct. None(TitleofClass) SecuritiesforwhichthereisareportingobligationpursuanttoSection15(d)oftheAct. None(TitleofClass) Indicatethenumberofoutstandingsharesofeachoftheissuer’sclassesofcapitalorcommonstockasofthecloseoftheperiodcoveredbytheannualreport(September30,2022):8,396,226 Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.Yes☐No☒ Ifthisreportisanannualortransitionreport,indicatebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934.Yes☐No☒ Note–CheckingtheboxabovewillnotrelieveanyregistrantrequiredtofilereportspursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934fromtheirobligationsunderthoseSections. Indicatebycheckmarkwhethertheregistrant(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtofilesuchreports),and(2)hasbeensubjecttosuchfilingrequirementsforthepast90days.Yes☒No☐ IndicatebycheckmarkwhethertheregistranthassubmittedelectronicallyeveryInteractiveDataFilerequiredtobesubmittedpursuanttoRule405ofRegulationS-T(§232.405ofthischapter)duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequiredtosubmitsuchfiles)Yes☒No☐ Indicatebycheckmarkwhethertheregistrantisalargeacceleratedfiler,anacceleratedfiler,anon-acceleratedfiler,oranemerginggrowthcompany.Seedefinitionof“largeacceleratedfiler,“acceleratedfiler,”and“emerginggrowthcompany”inRule12b-2oftheExchangeAct. LargeAcceleratedFiler ☐AcceleratedFiler ☐Non-AcceleratedFiler ☒EmergingGrowthCompany☒ IfanemerginggrowthcompanythatpreparesitsfinancialstatementsinaccordancewithU.S.GAAP,indicatebycheckmarkiftheregistranthaselectednottousetheextendedtransitionperiodforcomplying withanyneworrevisedfinancialaccountingstandards†providedpursuanttoSection13(a)oftheExchangeAct.☐ †Theterm“neworrevisedfinancialaccountingstandard”referstoanyupdateissuedbytheFinancialAccountingStandardsBoardtoitsAccountingStandardsCodificationafterApril5,2012. Indicatebycheckmarkwhichbasisofaccountingtheregistranthasusedtopreparethefinancialstatementsincludedinthisfiling: U.S.GAAP ☒ InternationalFinancialReportingStandardsasissuedbytheInternationalAccountingStandardsBoard☐ Other☐ If“Other”hasbeencheckedinresponsetothepreviousquestion,indicatebycheckmarkwhichfinancialstatementitemtheregistranthaselectedtofollow.☐Item17☐Item18 Ifthisisanannualreport,indicatebycheckmarkwhethertheregistrantisashellcompany(asdefinedinRule12b-2oftheExchangeAct).Yes☐No☒ (APPLICABLEONLYTOISSUERSINVOLVEDINBANKRUPTCYPROCEEDINGSDURINGTHEPASTFIVEYEARS) IndicatebycheckmarkwhethertheregistranthasfiledalldocumentsandreportsrequiredtobefiledbySections12,13or15(d)oftheSecuritiesExchangeActof1934subsequenttothedistributionofsecuritiesunderaplanconfirmedbyacourt.NotApplicable AnnualReportonForm20-FYearEndedSeptember30,2022 TABLEOFCONTENTS Page PARTI 2 ITEM1. IDENTITYOFDIRECTORS,SENIORMANAGEMENTANDADVISERS 2 A.DirectorsandSeniorManagement 2 B.Advisors 2 C.Auditors 2 ITEM2. OFFERSTATISTICSANDEXPECTEDTIMETABLE 2 A.OfferStatistics 2 B.MethodandExpectedTimetable 2 ITEM3. KEYINFORMATION 2 A.SelectedFinancialData 2 B.CapitalizationandIndebtedness 3 C.ReasonsfortheOfferandUseofProceeds 3 D.RiskFactors 3 ITEM4. INFORMATIONONTHECOMPANY 28 A.HistoryandDevelopmentoftheCompany 28 B.BusinessOverview 33 C.OrganizationalStructure 57 D.Property,PlantsandEquipment 58 ITEM4A. UNRESOLVEDSTAFFCOMMENTS 59 ITEM5. OPERATINGANDFINANCIALREVIEWANDPROSPECTS 59 A.OperatingResults 59 B.LiquidityandCapitalResources 73 C.ResearchandDevelopment,PatentsandLicenses,Etc. 75 D.TrendInform

你可能感兴趣

hot

天美生物2021年度报告

美股财报2022-01-31
hot

天美生物2023年度报告

美股财报2024-02-09